AbbVie Files 2024 10-K
Ticker: ABBV · Form: 10-K · Filed: 2025-02-14T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
AbbVie's 2024 10-K is in, check financials for the pharma giant.
AI Summary
AbbVie Inc. filed its 2024 10-K on February 14, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, a major player in pharmaceutical preparations, is incorporated in Delaware and headquartered in North Chicago, Illinois. The filing provides comprehensive financial data and business operations information for the period.
Why It Matters
This filing provides investors and analysts with a detailed look at AbbVie's financial health, operational performance, and strategic direction for the past fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: medium — This is a standard annual financial filing providing historical data, not indicating immediate new risks.
Key Players & Entities
- AbbVie Inc. (company) — Filer of the 10-K
- 20241231 (date) — Fiscal year end
- 20250214 (date) — Filing date
- North Chicago, IL (location) — Company headquarters
FAQ
What is AbbVie Inc.'s primary industry classification?
AbbVie Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was AbbVie Inc.'s 2024 10-K filed with the SEC?
The 10-K was filed on February 14, 2025.
What is the fiscal year end date for AbbVie Inc. in this filing?
The fiscal year end date is December 31, 2024.
Where is AbbVie Inc. headquartered?
AbbVie Inc. is headquartered in North Chicago, IL.
What is the SEC file number for AbbVie Inc.'s 10-K filings?
The SEC file number is 001-35565.
From the Filing
0001551152-25-000020.txt : 20250214 0001551152-25-000020.hdr.sgml : 20250214 20250214131723 ACCESSION NUMBER: 0001551152-25-000020 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 164 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250214 DATE AS OF CHANGE: 20250214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 25626115 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 10-K 1 abbv-20241231.htm 10-K abbv-20241231 0001551152 false 2024 FY http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#MoneyMarketFundsMember http://fasb.org/us-gaap/2024#MoneyMarketFundsMem